Trading Options with an Edge
Select Page

ALEC

Search by
TICKER SYMBOL

Alector Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

26.81

1.35

(5.302%)

Volume:

1,410,851

52 week range:

9.12 - 43.32

Market Cap:

2.168B

Company Description:

Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. The Company is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain's immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The Company's immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer's disease. This scientific approach is also the basis for the Company's immuno-oncology programs.